How many 8-K filings has Impact Biomedical Inc. filed?

Impact Biomedical Inc. (IBO) has 12 8-K (Current Event Report) filings on record, spanning Jan 2024 to Nov 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Impact Biomedical Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Impact Biomedical Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Impact Biomedical Inc. (IBO) — 8-K Filings

All 8-K filings from Impact Biomedical Inc.. Browse 12 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (12)

8-K Filing — Nov 6, 2025
Impact Biomedical Files 8-K: Other Events Reported — Oct 27, 2025 Risk: medium
Impact Biomedical Inc. filed an 8-K on October 27, 2025, reporting an "Other Events" item as of October 24, 2025. The filing does not contain specific details a
Impact Biomedical Inc. Signs Material Definitive Agreement — Jul 28, 2025 Risk: medium
Impact Biomedical Inc. entered into a material definitive agreement on July 21, 2025. The company, incorporated in Nevada with its principal executive offices i
Impact Biomedical Inc. Files 8-K for Material Agreement — Jun 23, 2025 Risk: medium
Impact Biomedical Inc. filed an 8-K on June 23, 2025, reporting a material definitive agreement entered into on June 21, 2025. The filing also includes Regulati
Impact Biomedical Inc. Enters Material Definitive Agreement — Apr 3, 2025 Risk: medium
On April 3, 2025, Impact Biomedical Inc. filed an 8-K report to disclose the entry into a Material Definitive Agreement. The filing does not provide specific de
Impact Biomedical Inc. Announces Executive and Director Changes — Mar 13, 2025 Risk: medium
Impact Biomedical Inc. announced on March 11, 2025, changes in its executive and director roles. The company filed an 8-K report detailing the departure of cert
8-K Filing — Jan 29, 2025
Impact Biomedical Inc. Files 8-K — Nov 4, 2024 Risk: low
Impact Biomedical Inc. filed an 8-K on November 4, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
Impact Biomedical Relocates HQ, Updates Contact Info — Oct 8, 2024 Risk: low
Impact Biomedical Inc. announced on October 3, 2024, a change in its principal executive offices to 1400 Broadfield Blvd., Suite 130, Houston, TX 77084. The com
Impact Biomedical Inc. Files 8-K for Material Agreement — Sep 17, 2024 Risk: medium
Impact Biomedical Inc. announced on September 16, 2024, that it entered into a material definitive agreement. The company also reported other events and filed f
Impact Biomedical Inc. Announces Board and Officer Changes — Jun 7, 2024 Risk: medium
Impact Biomedical Inc. announced on June 6, 2024, changes in its board and officer appointments. Specifically, the company elected new directors and appointed c
IMPACT BIOMEDICAL Enters Material Definitive Agreement — Jan 22, 2024
IMPACT BIOMEDICAL INC. filed an 8-K on January 22, 2024, reporting a material definitive agreement entered into on January 18, 2024. This filing indicates a sig

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX